Fundraising FoxOptum Ventures — 2023 Investments
2 investments dated 2023 · listed companies and verified rows first · show all
Holmusk builds real-world data and analytics products for neuropsychiatry, including NeuroBlu Data (de-identified patient records mapped from U.S. electronic health records) and NeuroBlu Analytics, an evidence engine that lets researchers build patient cohorts and run observational studies.
AI & Machine LearningData & InfrastructureDigital HealthMental HealthNew York, US
Nawal Roy(Founder)inTramontin Anthony David(Executive Officer, Director)Chik Wai Chiew(Director)Michael Weintraub(Director)
BoardCharles Andrew Boorady(Director)Vijay Prakash Barathan(Director)in
Co-investorsHealth Catalyst CapitalNorthwell Holdings
BehaVR develops VR-based (XR) therapeutics for mental and behavioral health, translating clinical science into immersive programs that address stress, anxiety, fear, pain management, addiction recovery, and maternal health.
Digital HealthHealthtechMental HealthElizabethtown, US
Aaron Gani(Executive Officer, Director)
Co-investorsChrysalis VenturesKeyhorse CapitalPoplar VenturesAccenture VenturesFrist Cressey VenturesFuture Labs Capital+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.